VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,985,563 | +1047.7% | 298,581 | +1944.4% | 0.00% | – |
| Q1 2022 | $173,000 | -29.7% | 14,605 | -0.6% | 0.00% | – |
| Q4 2021 | $246,000 | -98.0% | 14,686 | -97.9% | 0.00% | -100.0% |
| Q3 2021 | $12,322,000 | -17.1% | 711,463 | -0.5% | 0.01% | -14.3% |
| Q2 2021 | $14,866,000 | +640.0% | 714,760 | +490.9% | 0.01% | +600.0% |
| Q1 2021 | $2,009,000 | +2.7% | 120,956 | -13.7% | 0.00% | 0.0% |
| Q4 2020 | $1,956,000 | -22.9% | 140,111 | -44.4% | 0.00% | -50.0% |
| Q3 2020 | $2,538,000 | -16.3% | 252,090 | -3.6% | 0.00% | -33.3% |
| Q2 2020 | $3,032,000 | +7.0% | 261,606 | +1.8% | 0.00% | 0.0% |
| Q1 2020 | $2,833,000 | -33.9% | 257,106 | -1.5% | 0.00% | 0.0% |
| Q4 2019 | $4,285,000 | +309.7% | 261,107 | +231.6% | 0.00% | +200.0% |
| Q3 2019 | $1,046,000 | +18.6% | 78,747 | +25.8% | 0.00% | 0.0% |
| Q2 2019 | $882,000 | -29.8% | 62,588 | -8.4% | 0.00% | 0.0% |
| Q1 2019 | $1,257,000 | -41.3% | 68,319 | -16.7% | 0.00% | -50.0% |
| Q4 2018 | $2,143,000 | +1.1% | 81,981 | -11.3% | 0.00% | 0.0% |
| Q3 2018 | $2,120,000 | +43.8% | 92,379 | +19.4% | 0.00% | +100.0% |
| Q2 2018 | $1,474,000 | +10.9% | 77,349 | -1.9% | 0.00% | 0.0% |
| Q1 2018 | $1,329,000 | +21.6% | 78,882 | +9.8% | 0.00% | 0.0% |
| Q4 2017 | $1,093,000 | -18.4% | 71,855 | -3.9% | 0.00% | 0.0% |
| Q3 2017 | $1,339,000 | +1.1% | 74,765 | -8.0% | 0.00% | 0.0% |
| Q2 2017 | $1,324,000 | +800.7% | 81,247 | +672.3% | 0.00% | – |
| Q1 2017 | $147,000 | -18.8% | 10,520 | -4.2% | 0.00% | – |
| Q4 2016 | $181,000 | +27.5% | 10,976 | +28.7% | 0.00% | – |
| Q3 2016 | $142,000 | +7.6% | 8,529 | -27.6% | 0.00% | – |
| Q2 2016 | $132,000 | -98.5% | 11,782 | -98.9% | 0.00% | -100.0% |
| Q1 2016 | $9,090,000 | -19.2% | 1,087,319 | -10.1% | 0.01% | -23.1% |
| Q4 2015 | $11,255,000 | +1.7% | 1,208,918 | +23.3% | 0.01% | -13.3% |
| Q3 2015 | $11,064,000 | +1.0% | 980,844 | +13.7% | 0.02% | +15.4% |
| Q2 2015 | $10,951,000 | +78121.4% | 863,022 | +100251.4% | 0.01% | – |
| Q2 2014 | $14,000 | – | 860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |